Patients Coming Off Anti-Obesity Jabs Regain Weight Four Times Faster Than Dieters

Fresh analysis suggests that people who come off new GLP-1 drugs like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who end conventional diet and exercise programs.

Research printed in a leading health publication demonstrates that while overweight individuals often shed a large proportion of their total mass while undergoing treatment, the weight is regained at an average rate of 0.8 kg per month upon discontinuation.

"Individuals purchasing such treatments need to be informed of the potential of fast rebound weight gain when the therapy is stopped," stated lead investigator Dr. Susan Jebb.

That rate of recovery means a return to starting mass within about 18 months.

Weighing Approaches

The research, which reviewed 37 of studies involving thousands of patients, contrasted the results of these new drugs with conventional dieting.

The team emphasize that individuals who shed pounds through dieting usually experience a slower creep back—perhaps 100 grams monthly—after stopping.

Explaining the Fast Regain

Nutrition scientists propose the mode of action of the drugs is key to understanding the amplified weight return.

These medications copy a natural hormone called glucagon-like peptide-1, which controls hunger.

"Sustained high doses of the hormone concentrations several times higher than the body's typical production may cause the system to generate a reduced amount of its own natural GLP-1, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a nutrition expert.

"Withdrawal of this medication results in appetite is uncontrolled, making excessive eating a significant risk."

A Chronic Disease?

Health authorities recommend the jabs for people with weight-linked health risks, alongside recommended lifestyle changes.

Many experts say that, considering the high risk of relapse, the therapy should be considered long-term.

This opinion is reinforced by pharmaceutical companies, who say that the findings "underscore the long-term character of obesity," akin to managing diseases like high blood pressure.

User Testimonies

Individuals who have discontinued the jabs describe a powerful return of cravings.

"It felt as if a trigger activating and you become ravenous," described a patient.

The struggle is worsened if patients have not adopted sustainable dietary or behavioural changes during treatment.

Growing Interest

Figures show that millions of people in the UK have tried weight-loss jabs in the past year, with demand remaining high.

• Adoption is more common among women than men.
• The 40s and 50s age group shows the greatest level of interest.
• Many obtain the drugs through private prescriptions rather than the NHS.

In conclusion, experts emphasize that while GLP-1 drugs are powerful tools for shedding pounds, they are not a magic solution and maintained weight loss likely depends on integrated lifestyle support.